Please turn JavaScript on
Find more feeds
Oncology News, Insights, Stories by OncoDaily icon

Oncology News, Insights, Stories by OncoDaily

Want to stay in touch with the latest updates from Oncology News, Insights, Stories by OncoDaily? That's easy! Just subscribe clicking the Follow button below, choose topics or keywords for filtering if you want to, and we send the news to your inbox, to your phone via push notifications or we put them on your personal page here on follow.it.

Reading your RSS feed has never been easier!

Website title: Oncology News, Insights, Stories by OncoDaily

Is this your feed? Claim it!

Publisher:  Unclaimed!
Message frequency:  32.14 / day

Message History

George Calin: New Insights into Hypoxia-Driven miRNAs in Breast Cancer


George Calin, Professor at MD Anderson Cancer Center, shared on LinkedIn: “Just published in Molecular Aspects of Medicine (IF=13.8, Elsevier) by Sanjay Kumar and colleagues: ‘Unravelling the mystery of hypoxia-induced miRNAs in […]

Read full story
New Insights Into the Future of Liquid Biopsy in Cancer Immunotherapy – ELBS


European Liquid Biopsy Society (ELBS) shared on LinkedIn: “New insights into the future of liquid biopsy in cancer immunotherapy – with ELBS contributions We are excited to share this new […]

Read full story
Sara Gore Cancer Free After Breast Cancer Diagnosis and Surgery


NBC television host Sara Gore has shared encouraging news just months after revealing her breast cancer diagnosis. In a heartfelt Instagram update posted on July 12, 2026, the longtime New […]

Read full story
Sipuleucel-T Becomes the First FDA-Approved Therapeutic Cancer Vaccine for Metastatic Prostate Cancer


Immune Oncology Research Institute shared on LinkedIn: “What if the most powerful weapon against cancer could come from the patient’s own immune system? Sipuleucel-T demonstrated that this was possible, becoming […]

Read full story
Perioperative Immunotherapy in Locally Advanced Head and Neck Squamous Cell Carcinoma


For more than two decades, the treatment of locally advanced head and neck squamous cell carcinoma (LA-HNSCC)has changed very little. Surgery followed by risk-adapted radiotherapy or chemoradiotherapy has remained the […]

Read full story